What is the catalog number for Baicalein?

The catalog number for Baicalein is HY-N0196.

What sizes are available for Baicalein?

Baicalein is available in the following size(s): 100 mg, 10 mM - 1 mL, 500 mg, 1 g, 5 g.

How many pack sizes does Baicalein come in?

Baicalein is available in 5 different pack sizes.

Is Baicalein in stock?

Baicalein is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Baicalein?

Baicalein is manufactured by QuantiMol.

What is the estimated delivery time for Baicalein?

Estimated delivery time for Baicalein is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Baicalein?

The safety data sheet for Baicalein is available here: http://file.medchemexpress.com/batch_PDF/HY-N0196/Baicalein-SDS-MedChemExpress.pdf.

Baicalein

Baicalein (5,6,7-Trihydroxyflavone) is a xanthine oxidase inhibitor with an IC50 value of 3.12 μM.

Product Specifications

CAS Number

491-67-8

Product Name Alternative

5,6,7-Trihydroxyflavone

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Ferroptosis; Influenza Virus; Xanthine Oxidase

Type

Natural Products

Related Pathways

Anti-infection; Apoptosis; Metabolic Enzyme/Protease

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Baicalein.html

Purity

99.13

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C1C=C(C2=CC=CC=C2)OC3=CC(O)=C(O)C(O)=C13

Molecular Formula

C15H10O5

Molecular Weight

270.24

Precautions

H302, H315, H319, H335

References & Citations

[1]Shieh DE, et al. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 2000 Sep-Oct;20 (5A) :2861-5.|[2]Patwardhan RS, et al. Baicalein exhibits anti-inflammatory effects via inhibition of NF-κB transactivation. Biochem Pharmacol. 2016 May 15;108:75-89.|[3]Ma X, et al. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Drug Des Devel Ther. 2016 Apr 18;10:1419-41.|[4]Kong EK, et al. A novel anti-fibrotic agent, baicalein, for the treatment of myocardial fibrosis in spontaneously hypertensiverats. Eur J Pharmacol. 2011 May 11;658 (2-3) :175-81.